LASP1 and liver cancer: Taken together, these data suggested that the ubiquitination of LASP1 mediated by TRIM15 promoted LASP1 nuclear translocation to activate the AKT signaling pathway, which was responsible for inducing sorafenib resistance in liver cancer cells.